Your browser doesn't support javascript.
loading
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by ß-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
Torres, Antoni; Wible, Michele; Tawadrous, Margaret; Irani, Paurus; Stone, Gregory G; Quintana, Alvaro; Debabov, Dmitri; Burroughs, Margaret; Bradford, Patricia A; Kollef, Marin.
Affiliation
  • Torres A; Servei de Pneumologia, Hospital Clinic, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain.
  • Wible M; Pfizer, Collegeville, PA, USA.
  • Tawadrous M; Hospital Business Unit, Pfizer, Groton, CT, USA.
  • Irani P; Hospital Business Unit, Pfizer, Tadworth, Surrey, UK.
  • Stone GG; Hospital Business Unit, Pfizer, Groton, CT, USA.
  • Quintana A; Hospital Business Unit, Pfizer, New York, NY, USA.
  • Debabov D; Non-clinical Development Microbiology, AbbVie, Irvine, CA, USA.
  • Burroughs M; Global Pharmaceutical R&D, AbbVie, Madison, NJ, USA.
  • Bradford PA; Antimicrobial Development Specialists, LLC, Nyack, NY, USA.
  • Kollef M; Division of Pulmonary & Critical Care Medicine, Institute of Clinical and Translational Sciences, Washington University School of Medicine, St Louis, MO, USA.
J Antimicrob Chemother ; 78(11): 2672-2682, 2023 11 06.
Article in En | MEDLINE | ID: mdl-37700689

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract Infections / Intraabdominal Infections Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: J Antimicrob Chemother Year: 2023 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract Infections / Intraabdominal Infections Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: J Antimicrob Chemother Year: 2023 Type: Article Affiliation country: Spain